Baillie Gifford & Co’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-108
| Closed | -$16.7K | – | 371 |
|
|
2023
Q1 | $16.7K | Hold |
108
| – | – | ﹤0.01% | 354 |
|
|
2022
Q4 | $19.1K | Buy |
108
+9
| +9% | +$1.55K | ﹤0.01% | 352 |
|
|
2022
Q3 | $16K | Hold |
99
| – | – | ﹤0.01% | 360 |
|
|
2022
Q2 | $18K | Buy |
99
+10
| +11% | +$1.78K | ﹤0.01% | 351 |
|
|
2022
Q1 | $16K | Hold |
89
| – | – | ﹤0.01% | 392 |
|
|
2021
Q4 | $15K | Hold |
89
| – | – | ﹤0.01% | 408 |
|
|
2021
Q3 | $14K | Hold |
89
| – | – | ﹤0.01% | 412 |
|
|
2021
Q2 | $15K | Hold |
89
| – | – | ﹤0.01% | 385 |
|
|
2021
Q1 | $15K | Buy |
89
+1
| +1% | +$162 | ﹤0.01% | 363 |
|
|
2020
Q4 | $14K | Buy |
+88
| New | +$13K | ﹤0.01% | 358 |
|
|
2019
Q3 | – | Sell |
-105,784
| Closed | -$14.7M | – | 229 |
|
|
2019
Q2 | $14.7M | Buy |
105,784
+2,638
| +3% | +$365K | 0.02% | 174 |
|
|
2019
Q1 | $14.4M | Buy |
103,146
+8,280
| +9% | +$1.11M | 0.02% | 177 |
|
|
2018
Q4 | $12.2M | Sell |
94,866
-127,011
| -57% | -$17.7M | 0.02% | 178 |
|
|
2018
Q3 | $30.7M | Sell |
221,877
-53,673
| -19% | -$7.13M | 0.03% | 134 |
|
|
2018
Q2 | $33.4M | Buy |
275,550
+9,185
| +3% | +$1.15M | 0.04% | 128 |
|
|
2018
Q1 | $34.1M | Sell |
266,365
-4,036
| -1% | -$546K | 0.04% | 120 |
|
|
2017
Q4 | $37.8M | Sell |
270,401
-78
| -0% | -$10.9K | 0.05% | 110 |
|
|
2017
Q3 | $35.2M | Buy |
270,479
+11,071
| +4% | +$1.47M | 0.04% | 109 |
|
|
2017
Q2 | $34.3M | Buy |
259,408
+18,454
| +8% | +$2.35M | 0.05% | 111 |
|
|
2017
Q1 | $30M | Buy |
240,954
+4,328
| +2% | +$517K | 0.04% | 108 |
|
|
2016
Q4 | $27.3M | Buy |
236,626
+6,110
| +3% | +$706K | 0.04% | 104 |
|
|
2016
Q3 | $27.2M | Sell |
230,516
-13,106
| -5% | -$1.59M | 0.04% | 107 |
|
|
2016
Q2 | $29.6M | Buy |
243,622
+58,245
| +31% | +$6.62M | 0.05% | 100 |
|
|
2016
Q1 | $20.1M | Buy |
185,377
+6,113
| +3% | +$633K | 0.04% | 120 |
|
|
2015
Q4 | $18.4M | Buy |
179,264
+9,198
| +5% | +$925K | 0.03% | 119 |
|
|
2015
Q3 | $15.9M | Hold |
170,066
| – | – | 0.03% | 129 |
|
|
2015
Q2 | $16.6M | Sell |
170,066
-600,042
| -78% | -$60.1M | 0.03% | 122 |
|
|
2015
Q1 | $77.5M | Sell |
770,108
-661,056
| -46% | -$67.2M | 0.15% | 87 |
|
|
2014
Q4 | $150M | Sell |
1,431,164
-361,364
| -20% | -$38.1M | 0.3% | 63 |
|
|
2014
Q3 | $191M | Sell |
1,792,528
-322,225
| -15% | -$33.4M | 0.42% | 59 |
|
|
2014
Q2 | $221M | Buy |
2,114,753
+303,532
| +17% | +$30.7M | 0.48% | 57 |
|
|
2014
Q1 | $178M | Buy |
1,811,221
+29,436
| +2% | +$2.73M | 0.42% | 59 |
|
|
2013
Q4 | $163M | Sell |
1,781,785
-30,174
| -2% | -$2.78M | 0.39% | 58 |
|
|
2013
Q3 | $157M | Buy |
1,811,959
+545,518
| +43% | +$48.9M | 0.4% | 57 |
|
|
2013
Q2 | $109M | Buy |
+1,266,441
| New | +$107M | 0.33% | 62 |
|
Other funds holding JNJ
Baillie Gifford & Co's JNJ Position: Q2 2023 in Review
Baillie Gifford & Co sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 108 shares — an estimated $16.7K sold.
Baillie Gifford & Co first reported a position in JNJ in Q2 2013 and held it in 35 quarters. The position peaked at $221M in Q2 2014. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.
- Baillie Gifford & Co reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
- Baillie Gifford & Co sold 108 Johnson & Johnson shares in Q2 2023, an estimated $16.7K.
- Baillie Gifford & Co first reported a position in Johnson & Johnson in Q2 2013 and held it in 35 quarters.
- Baillie Gifford & Co's Johnson & Johnson position peaked at $221M in Q2 2014.
- 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.
Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.